BNTX · BioNTech SE ADR
United States · RS rating 28 · As of 2026-10-14
| Price | 88.66 USD |
|---|---|
| 1-day change | -0.4% |
| RS rating (overall / 1M / 3M / 12M) | 28 / 27 / 50 / 30 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 23 / 23 / 19 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -941.7% |
| Sales growth Q/Q | -40.3% |
| Distance from 52-week high | +25.7% |
| Market cap (USD) | $26.7B |